AstraZeneca (AZN) News Today → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free AZN Stock Alerts $68.36 -0.17 (-0.25%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ2 2025 Earnings Forecast for AstraZeneca PLC (NASDAQ:AZN) Issued By Zacks Researchmarketbeat.com - April 18 at 6:31 AMAstraZeneca (AZN) to Release Earnings on Thursdayamericanbankingnews.com - April 18 at 1:08 AMAmgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pickbenzinga.com - April 17 at 3:12 PMAstraZeneca (NASDAQ:AZN) Upgraded to Hold at Deutsche Bank Aktiengesellschaftamericanbankingnews.com - April 17 at 4:10 AMAstraZeneca (NASDAQ:AZN) Upgraded at Deutsche Bank Aktiengesellschaftmarketbeat.com - April 16 at 1:28 PMAstraZeneca's Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Showsbenzinga.com - April 16 at 9:42 AMAsher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trialsbusinesswire.com - April 16 at 8:00 AMCerity Partners LLC Raises Holdings in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 16 at 5:52 AM3 Pharma Stocks That Are Money-Printing Machines in 2024investorplace.com - April 15 at 5:51 PMFlputnam Investment Management Co. Has $18.33 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 15 at 5:35 PMInternational Assets Investment Management LLC Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 14 at 4:42 AMWCM Investment Management LLC Cuts Holdings in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 13 at 1:54 PMAstraZeneca (NASDAQ:AZN) Shares Gap Up to $68.11americanbankingnews.com - April 13 at 5:42 AMAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Hardman Johnston Global Advisors LLCmarketbeat.com - April 12 at 9:29 PMAstraZeneca PLC (NASDAQ:AZN) Sees Significant Decline in Short Interestmarketbeat.com - April 12 at 9:16 AMTraders Buy High Volume of AstraZeneca Put Options (NASDAQ:AZN)americanbankingnews.com - April 12 at 3:48 AMAstraZeneca Sees Unusually Large Options Volume (NASDAQ:AZN)marketbeat.com - April 11 at 2:49 PMFTSE 100 Live: Stocks slip as AstraZeneca pay vote nears; market targets September rate cutuk.investing.com - April 11 at 9:50 AMSpotlight on FTSE 100 stock AstraZenecamsn.com - April 11 at 9:50 AMAstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boostbenzinga.com - April 11 at 9:50 AMFASENRA approved for treatment of children aged 6 to 11 with severe asthmabusinesswire.com - April 11 at 7:00 AMAstraZeneca promises dividend rise ahead of vote on chief’s £18.7m pay dealmsn.com - April 11 at 4:50 AMAstraZeneca unveils dividend hike ahead of CEO pay vote at AGMmsn.com - April 11 at 4:50 AMAstraZeneca unveils dividend hike ahead of CEO pay vote at AGMreuters.com - April 11 at 2:30 AMAstraZeneca’s Enhertu Approval Spurs Buy Rating Amid Revenue Growth Projectionsmarkets.businessinsider.com - April 10 at 7:27 AMFY2026 EPS Estimates for AstraZeneca PLC (NASDAQ:AZN) Lifted by Analystamericanbankingnews.com - April 10 at 2:34 AMZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?finance.yahoo.com - April 10 at 1:21 AMMeet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.barrons.com - April 9 at 11:42 AMResearch Analysts Issue Forecasts for AstraZeneca PLC's FY2026 Earnings (NASDAQ:AZN)marketbeat.com - April 9 at 6:25 AMFirst Merchants Corp Makes New $3.89 Million Investment in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 7 at 4:21 PMIncreases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca PLC (LON:AZN)finance.yahoo.com - April 6 at 7:23 AMENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumorsbusinesswire.com - April 5 at 11:10 PMFDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatmentmarkets.businessinsider.com - April 5 at 10:46 PMENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumorsbusinesswire.com - April 5 at 9:43 PMUS FDA approves Daiichi, AstraZeneca drug for treatment of solid tumorsreuters.com - April 5 at 5:45 PMNew Hope for Aggressive Lung Cancer: AstraZeneca's Imfinzi Shows Promising Results in Phase 3 Trialmsn.com - April 5 at 12:44 PMAstraZeneca Imfinzi improves survival in late-stage lung cancer trialmsn.com - April 5 at 8:44 AMAstraZeneca's Imfinzi shows promise in treating aggressive lung cancerreuters.com - April 5 at 2:43 AMAstraZeneca PLC (NASDAQ:AZN) Shares Acquired by China Universal Asset Management Co. Ltd.marketbeat.com - April 4 at 6:45 PMAstraZeneca (NASDAQ:AZN) Shares Gap Up to $66.81marketbeat.com - April 4 at 1:21 PMZacks Research Weighs in on AstraZeneca PLC's Q1 2025 Earnings (NASDAQ:AZN)marketbeat.com - April 4 at 9:29 AMHealthy Returns: Weight loss, diabetes drug ad spending tops $1 billioncnbc.com - April 3 at 1:33 PMMiracle Mile Advisors LLC Cuts Stock Position in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 3 at 5:27 AMTIAA Trust National Association Sells 29,621 Shares of AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 2 at 5:09 PMAstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Racebenzinga.com - April 2 at 3:26 PMFDA accepts Daiichi Sankyo-AstraZeneca's breast cancer therapy for reviewmsn.com - April 2 at 8:36 AMDatopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancerbusinesswire.com - April 2 at 2:00 AMAstraZeneca gets FDA approval for PNH drug Voydeyamsn.com - April 1 at 3:34 PMAstraZeneca gets FDA OK for rare disease drug acquired in Alexion buyoutfinance.yahoo.com - April 1 at 8:56 AMChicago Capital LLC Buys New Holdings in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 1 at 8:48 AM Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AI “wealth window” is closing soon! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry. I put together this personal video [HERE]… AZN Media Mentions By Week AZN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.700.50▲Average Medical News Sentiment AZN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼1814▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Novartis News Abbott Laboratories News Pfizer News AbbVie News Sanofi News Bristol-Myers Squibb News Vertex Pharmaceuticals News Regeneron Pharmaceuticals News Merck & Co., Inc. News GSK News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressBiden’s $374B Giveaway Into This SectorDTIA.I. Pioneer Issues Urgent Warning to AmericansTradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & CompanyTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.